Downregulation of MYCN through PI3K Inhibition in Mouse Models of Pediatric Neural Cancer

The MYCN proto-oncogene is associated with poor outcome across a broad range of pediatric tumors. While amplification of MYCN drives subsets of high-risk neuroblastoma and medulloblastoma, dysregulation of MYCN in medulloblastoma (in the absence of amplification) also contributes to pathogenesis. Si...

Descripción completa

Detalles Bibliográficos
Autores principales: Cage, Tene Aneka, Chanthery, Yvan, Chesler, Louis, Grimmer, Matthew, Knight, Zachary, Shokat, Kevan, Weiss, William A., Gustafson, W. Clay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429235/
https://www.ncbi.nlm.nih.gov/pubmed/26029667
http://dx.doi.org/10.3389/fonc.2015.00111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429235/
https://www.ncbi.nlm.nih.gov/pubmed/26029667
http://dx.doi.org/10.3389/fonc.2015.00111

Ejemplares similares